Search
for
Sort by
Research 601–630 of 1000+
- The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
- Timing of expression of the core clock gene <i>Bmal1</i> influences its effects on aging and survival
- Polycystic Ovary Syndrome
- An integrative view of mammalian seasonal neuroendocrinology
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Metabolism and skin diseases
- An update of polycystic ovary syndrome: causes and therapeutics options
- Impact of a health coaching intervention on anthropometric indicators, physical activity, and life style of infertile women with polycystic ovary syndrome: A quasi-experimental study
- Mini Review on Polycystic Ovary Syndrome (PCOS)
- Follikelhormone
- Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia.
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
- Screening for 21-hydroxylase–deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study
- Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial
- Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes
- The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women
- The influence of androgens on insulin resistance
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Treatment of hyperandrogenic alopecia in women
- Defining hirsutism in Chinese women: a cross-sectional study
- Evaluation of Hirsutism and Hyperandrogenemia
- Safety of testosterone treatment in postmenopausal women
- Current evaluation of amenorrhea
- Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism
- Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects
- Outcome of long-term treatment with the 5α-reductase inhibitor finasteride in idiopathic hirsutism: clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up
- Clinical and endocrine effects of finasteride, a 5α-reductase inhibitor, in women with idiopathic hirsutism
- Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism